Riccardo Dalla‐Favera

55.8k total citations · 20 hit papers
300 papers, 40.4k citations indexed

About

Riccardo Dalla‐Favera is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Riccardo Dalla‐Favera has authored 300 papers receiving a total of 40.4k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Pathology and Forensic Medicine, 126 papers in Oncology and 112 papers in Immunology. Recurrent topics in Riccardo Dalla‐Favera's work include Lymphoma Diagnosis and Treatment (161 papers), Chronic Lymphocytic Leukemia Research (109 papers) and Viral-associated cancers and disorders (65 papers). Riccardo Dalla‐Favera is often cited by papers focused on Lymphoma Diagnosis and Treatment (161 papers), Chronic Lymphocytic Leukemia Research (109 papers) and Viral-associated cancers and disorders (65 papers). Riccardo Dalla‐Favera collaborates with scholars based in United States, Italy and France. Riccardo Dalla‐Favera's co-authors include Katia Basso, Ulf Klein, Laura Pasqualucci, Gianluca Gaïdano, Andrea Califano, Giorgio Cattoretti, Robert C. Gallo, R. S. K. Chaganti, Antonino Neri and Giorgio Inghirami and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Riccardo Dalla‐Favera

293 papers receiving 39.5k citations

Hit Papers

Human c-myc onc gene is l... 1982 2026 1996 2011 1982 2005 1997 2009 1991 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.
    1982 1.4k citations Riccardo Dalla‐Favera et al. Proceedings of the National Academy of Sciences profile →
  2. Reverse engineering of regulatory networks in human B cells
    2005 1.0k citations Katia Basso, Riccardo Dalla‐Favera et al. profile →
  3. c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
    1997 877 citations Riccardo Dalla‐Favera, Chi V. Dang et al. Proceedings of the National Academy of Sciences profile →
  4. Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
    2009 795 citations Mara Compagno, Subhadra V. Nandula et al. profile →
  5. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.
    1991 746 citations Gianluca Gaïdano, Giorgio Inghirami et al. Proceedings of the National Academy of Sciences profile →
  6. Direct activation of TERT transcription by c-MYC
    1999 734 citations Carla Grandori, Riccardo Dalla‐Favera et al. profile →
  7. Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells
    2001 704 citations Giorgio Cattoretti, Giorgio Inghirami et al. The Journal of Experimental Medicine profile →
  8. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
    1997 682 citations Giorgio Cattoretti, Qiong Shen et al. profile →
  9. Analysis of the coding genome of diffuse large B-cell lymphoma
    2011 673 citations Laura Pasqualucci, Davide Rossi et al. profile →
  10. Inactivating mutations of acetyltransferase genes in B-cell lymphoma
    2011 644 citations Laura Pasqualucci, David Dominguez-Sola et al. profile →
  11. Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4
    2002 642 citations Riccardo Dalla‐Favera et al. Nature Immunology profile →
  12. Germinal centres: role in B-cell physiology and malignancy
    2007 606 citations Riccardo Dalla‐Favera et al. profile →
  13. The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
    2010 600 citations Qiong Shen, Tongwei Mo et al. profile →
  14. Alterations of a Zinc Finger-Encoding Gene, BCL-6 , in Diffuse Large-Cell Lymphoma
    1993 580 citations Riccardo Dalla‐Favera et al. profile →
  15. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
    2006 570 citations Giorgio Cattoretti, Qiong Shen et al. Nature Immunology profile →
  16. Non-transcriptional control of DNA replication by c-Myc
    2007 519 citations David Dominguez-Sola, Carol Y. Ying et al. profile →
  17. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells
    2004 510 citations Riccardo Dalla‐Favera et al. profile →
  18. Expression of cellular homologues of retroviral onc genes in human hematopoietic cells.
    1982 497 citations Riccardo Dalla‐Favera et al. Proceedings of the National Academy of Sciences profile →
  19. Translocation and Rearrangements of the c- myc Oncogene Locus in Human Undifferentiated B-Cell Lymphomas
    1983 429 citations Riccardo Dalla‐Favera et al. profile →
  20. Genetics of Follicular Lymphoma Transformation
    2014 376 citations Laura Pasqualucci, Marco Fangazio et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Riccardo Dalla‐Favera United States 113 16.4k 15.2k 14.4k 13.0k 9.3k 300 40.4k
Louis M. Staudt United States 97 15.4k 0.9× 10.8k 0.7× 9.4k 0.7× 11.3k 0.9× 6.3k 0.7× 293 34.8k
Ronald Levy United States 109 11.4k 0.7× 12.8k 0.8× 14.4k 1.0× 20.4k 1.6× 8.4k 0.9× 694 44.9k
Brunangelo Falini Italy 86 9.3k 0.6× 15.5k 1.0× 10.7k 0.7× 7.8k 0.6× 7.6k 0.8× 390 32.9k
Scott J. Rodig United States 85 10.5k 0.6× 8.2k 0.5× 18.7k 1.3× 10.9k 0.8× 3.9k 0.4× 347 33.8k
Peter Lichter Germany 100 19.4k 1.2× 7.5k 0.5× 6.7k 0.5× 5.3k 0.4× 11.9k 1.3× 490 36.6k
Mark Raffeld United States 90 6.6k 0.4× 11.0k 0.7× 14.1k 1.0× 7.8k 0.6× 5.5k 0.6× 428 27.4k
Thomas J. Kipps United States 91 11.7k 0.7× 13.2k 0.9× 7.6k 0.5× 14.8k 1.1× 19.7k 2.1× 622 35.2k
Ash A. Alizadeh United States 66 15.5k 0.9× 4.7k 0.3× 11.0k 0.8× 10.6k 0.8× 2.8k 0.3× 251 35.5k
Andreas Rosenwald Germany 73 6.1k 0.4× 10.6k 0.7× 7.6k 0.5× 5.6k 0.4× 6.1k 0.7× 421 20.3k
Margaret A. Shipp United States 70 6.2k 0.4× 12.8k 0.8× 13.8k 1.0× 7.7k 0.6× 4.5k 0.5× 210 24.6k

Countries citing papers authored by Riccardo Dalla‐Favera

Since Specialization
Citations

This map shows the geographic impact of Riccardo Dalla‐Favera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riccardo Dalla‐Favera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riccardo Dalla‐Favera more than expected).

Fields of papers citing papers by Riccardo Dalla‐Favera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riccardo Dalla‐Favera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riccardo Dalla‐Favera. The network helps show where Riccardo Dalla‐Favera may publish in the future.

Co-authorship network of co-authors of Riccardo Dalla‐Favera

This figure shows the co-authorship network connecting the top 25 collaborators of Riccardo Dalla‐Favera. A scholar is included among the top collaborators of Riccardo Dalla‐Favera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riccardo Dalla‐Favera. Riccardo Dalla‐Favera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Andrew, Yunchao Chang, Antony B. Holmes, et al.. (2024). Differential Role of Crebbp Missense and Truncating Mutations in the Malignant Transformation of Germinal Center B Cells. Blood. 144(Supplement 1). 47–47.
2.
Scuoppo, Claudio, Cai Bowen, Kenneth Ofori, et al.. (2024). Repurposing NAMPT Inhibitors for Germinal Center B Cell–Like Diffuse Large B-Cell Lymphoma. Blood Cancer Discovery. 5(6). 417–427.
3.
Shen, Qiong, Antony B. Holmes, Tongwei Mo, et al.. (2024). MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis. Nature Communications. 15(1). 7195–7195. 1 indexed citations
4.
Vlasevska, Sofija, Laura Garcia‐Ibanez, Romain Duval, et al.. (2023). KMT2D acetylation by CREBBP reveals a cooperative functional interaction at enhancers in normal and malignant germinal center B cells. Proceedings of the National Academy of Sciences. 120(11). e2218330120–e2218330120. 8 indexed citations
5.
Anderson, Kenneth C., Lewis C. Cantley, Riccardo Dalla‐Favera, et al.. (2022). The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Cancer Discovery. 12(11). 2475–2481.
6.
Anderson, Kenneth C., Lewis C. Cantley, Riccardo Dalla‐Favera, et al.. (2022). The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Blood Cancer Discovery. 3(6). 469–475.
7.
Fangazio, Marco, Erik Ladewig, Laura Garcia‐Ibanez, et al.. (2021). Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences. 118(22). 53 indexed citations
8.
Scuoppo, Claudio, Jiguang Wang, Mirjana Persaud, et al.. (2019). Repurposing dasatinib for diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences. 116(34). 16981–16986. 27 indexed citations
9.
Bosch, Francesc & Riccardo Dalla‐Favera. (2019). Chronic lymphocytic leukaemia: from genetics to treatment. Nature Reviews Clinical Oncology. 16(11). 684–701. 163 indexed citations
10.
Pasqualucci, Laura & Riccardo Dalla‐Favera. (2018). Genetics of diffuse large B-cell lymphoma. Blood. 131(21). 2307–2319. 174 indexed citations
11.
Zhang, Jiyuan, Sofija Vlasevska, Victoria A. Wells, et al.. (2017). The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma. Cancer Discovery. 7(3). 322–337. 151 indexed citations
12.
Ying, Carol Y., David Dominguez-Sola, Ivo C. Lorenz, et al.. (2013). MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma. Nature Immunology. 14(10). 1084–1092. 122 indexed citations
13.
Basso, Katia, Christof Schneider, Qiong Shen, et al.. (2012). BCL6 positively regulates AID and germinal center gene expression via repression of miR-155. The Journal of Experimental Medicine. 209(13). 2455–2465. 95 indexed citations
14.
Gaïdano, Gianluca, Robin Foà, & Riccardo Dalla‐Favera. (2012). Molecular pathogenesis of chronic lymphocytic leukemia. Journal of Clinical Investigation. 122(10). 3432–3438. 116 indexed citations
15.
Green, Michael R., Stefano Monti, Riccardo Dalla‐Favera, et al.. (2011). Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program. Proceedings of the National Academy of Sciences. 108(7). 2873–2878. 42 indexed citations
16.
Cattoretti, Giorgio, Jonathan Mandelbaum, Nancy Lee, et al.. (2009). Targeted Disruption of the S1P 2 Sphingosine 1-Phosphate Receptor Gene Leads to Diffuse Large B-Cell Lymphoma Formation. Cancer Research. 69(22). 8686–8692. 103 indexed citations
17.
Novak, Urban, Andrea Rinaldi, Ivo Kwee, et al.. (2009). The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood. 113(20). 4918–4921. 184 indexed citations
18.
Piovan, Erich, Valeria Tosello, Stefano Indraccolo, et al.. (2007). Differential Regulation of Hypoxia-Induced CXCR4 Triggering during B-Cell Development and Lymphomagenesis. Cancer Research. 67(18). 8605–8614. 35 indexed citations
19.
Grandori, Carla, Kou-Juey Wu, Paula Fernández, et al.. (2003). Werner syndrome protein limits MYC-induced cellular senescence. Genes & Development. 17(13). 1569–1574. 146 indexed citations
20.
Neri, Antonino, James P. Murphy, Lilla Cro, et al.. (1989). Ras oncogene mutation in multiple myeloma.. The Journal of Experimental Medicine. 170(5). 1715–1725. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis M. Staudt Breakdown of academic impact, for papers by Ronald Levy Breakdown of academic impact, for papers by Brunangelo Falini Breakdown of academic impact, for papers by Scott J. Rodig Breakdown of academic impact, for papers by Peter Lichter Breakdown of academic impact, for papers by Mark Raffeld Breakdown of academic impact, for papers by Thomas J. Kipps Breakdown of academic impact, for papers by Ash A. Alizadeh Breakdown of academic impact, for papers by Andreas Rosenwald Breakdown of academic impact, for papers by Margaret A. Shipp
Rankless by CCL
2026